The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

UAE President honours Zayed Award for Human Fraternity winners
UAE hosts second round of trilateral talks on Ukraine
UAE expert named on UN panel shaping global AI governance
Dubai unveils Blue and Green Spaces Roadmap to improve quality of life
